Hancock Whitney Corporation - 6
Hancock Whitney Corporation - 6 (HWCPZ) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Hancock Whitney Corporation - 6 (HWCPZ), featuring income statements, balance sheets, and cash flow data.
Hancock Whitney Corporation - 6 (HWCPZ) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Hancock Whitney Corporation - 6 HWCPZ financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | -$488.23M | $488.25M | $504.44M | $522.43M |
| Cost of Revenue | $135.88M | $135.88M | $152.64M | $176.28M |
| Gross Profit | -$352.38M | $352.38M | $351.80M | $346.15M |
| Gross Profit Ratio | $0.72 | $0.72 | $0.70 | $0.66 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $118.50M | $118.50M | $116.92M | $120.19M |
| Operating Expenses | $118.50M | $203.20M | $201.28M | $200.90M |
| Total Costs & Expenses | $254.38M | $339.08M | $353.92M | $377.17M |
| Interest Income | -$395.32M | $395.32M | $414.29M | $429.48M |
| Interest Expense | -$125.42M | $125.42M | $140.73M | $157.71M |
| Depreciation & Amortization | -$9.90M | $9.90M | $9.98M | $10.45M |
| EBITDA | $9.26M | $159.08M | $160.50M | $155.71M |
| EBITDA Ratio | -$0.02 | $0.33 | $0.32 | $0.30 |
| Operating Income | -$149.18M | $149.18M | $150.52M | $145.26M |
| Operating Income Ratio | $0.31 | $0.31 | $0.30 | $0.28 |
| Other Income/Expenses (Net) | $293.75M | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $144.58M | $149.18M | $150.52M | $145.26M |
| Income Before Tax Ratio | -$0.30 | $0.31 | $0.30 | $0.28 |
| Income Tax Expense | $31.05M | $29.67M | $28.45M | $29.68M |
| Net Income | $113.53M | $119.50M | $122.07M | $115.57M |
| Net Income Ratio | -$0.23 | $0.24 | $0.24 | $0.22 |
| EPS | $1.31 | $1.38 | $1.41 | $1.33 |
| Diluted EPS | $1.31 | $1.38 | $1.40 | $1.33 |
| Weighted Avg Shares Outstanding | $86.20M | $86.46M | $86.35M | $86.23M |
| Weighted Avg Shares Outstanding (Diluted) | $86.20M | $86.46M | $86.60M | $86.56M |
The company's financials show resilient growth, with revenue advancing from $522.43M in Q3 2024 to -$488.23M in Q2 2025. Gross profit remained healthy with margins at 72% in Q2 2025 compared to 66% in Q3 2024. Operating income hit -$149.18M last quarter, sustaining a consistent 31% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $9.26M. Net income dropped to $113.53M, while earnings per share reached $1.31. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan